Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.985280
Abstract: T cell immune dysfunction is a prominent characteristic of chronic lymphocytic leukemia (CLL) and the main cause of failure for immunotherapy and multi-drug resistance. There remains a lack of specific biomarkers for evaluating T cell… read more here.
Keywords: prognosis; tcf1; expression; tcf1 bcl11b ... See more keywords